Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, and Steering Committee Member at Lung Cancer Policy Network, shared a post on X:
“Welcomed delegation from Amgen, Amgen Oncology together with GBAICTI and OASES of HKSARGovt to our CUHK Medicine (Faculty of Medicine of The Chinese University of Hong Kong) Phase 1 Clinical Trial Centre.
Discussions and plans on how we can synergise and propel the Greater Bay Area into a dynamic and influential drug development hub globally.”
More posts featuring Herbert Loong.